Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus Abd A. TahraniMilan K. PiyaAnthony H. Barnett Review 27 March 2009 Pages: 249 - 262
An overview of HER-targeted therapy with lapatinib in breast cancer Heather McArthur Review 27 March 2009 Pages: 263 - 271
DPP4 inhibitors: from sitagliptin monotherapy to the new alogliptin-pioglitazone combination therapy Georgia ArgyrakopoulouJohn Doupis Review 02 March 2009 Pages: 272 - 280
Teratogenesis associated with antibipolar agents Ha T. T. NguyenVerinder SharmaRoger S. McIntyre Review 28 March 2009 Pages: 281 - 294
Optimal treatment of obstructive sleep apnea and excessive sleepiness Russell RosenbergPaul Doghramji Review 03 April 2009 Pages: 295 - 312
Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria Osvaldo Kohlmann Jr.Alejandro Roca-CusachsRoberto Fogari Original Research 28 March 2009 Pages: 313 - 324
Baseline characteristics of the Indian cohort from the IMPROVE™ study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes Siddharth ShahA. K. DasR. K. Sahay Original Research 27 February 2009 Pages: 325 - 335
The Ex-PRESS glaucoma shunt versus trabeculectomy in open-angle glaucoma: a prospective randomized study Leo A. M. S. de Jong Original Research 03 April 2009 Pages: 336 - 345
Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis Kit N. SimpsonMary Jane WelchZiad Nahas Original Research 28 March 2009 Pages: 346 - 368
